m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00362)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
PDK1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Browse Drug
Fat mass and obesity-associated protein (FTO) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by FTO | ||
Cell Line | NB4 cell line | Homo sapiens |
Treatment: shFTO NB4 cells
Control: shNS NB4 cells
|
GSE103494 | |
Regulation |
|
logFC: -7.19E-01 p-value: 8.18E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDH kinase 1 (PDK1) mRNA in an m6A-dependent manner in glioblastoma multiforme cells. JPX interacted with N6-methyladenosine (m6A) demethylase FTO alpha-ketoglutarate dependent dioxygenase (FTO) and enhanced FTO-mediated PDK1 mRNA demethylation. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Glioblastoma | ICD-11: 2A00.00 | ||
Responsed Drug | Temozolomide | Approved | ||
Pathway Response | Citrate cycle | hsa00020 | ||
Central carbon metabolism in cancer | hsa05230 | |||
Cell Process | Aerobic glycolysis | |||
Cell apoptosis | ||||
In-vitro Model | LN-18 | Glioblastoma | Homo sapiens | CVCL_0392 |
LN-229 | Glioblastoma | Homo sapiens | CVCL_0393 | |
SHG-44 | Astrocytoma | Homo sapiens | CVCL_6728 | |
U251 (Fibroblasts or fibroblast like cells) | ||||
U87 (A primary glioblastoma cell line) | ||||
Brain cancer [ICD-11: 2A00]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDH kinase 1 (PDK1) mRNA in an m6A-dependent manner in glioblastoma multiforme cells. JPX interacted with N6-methyladenosine (m6A) demethylase FTO alpha-ketoglutarate dependent dioxygenase (FTO) and enhanced FTO-mediated PDK1 mRNA demethylation. | |||
Responsed Disease | Glioblastoma [ICD-11: 2A00.00] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Responsed Drug | Temozolomide | Approved | ||
Pathway Response | Citrate cycle | hsa00020 | ||
Central carbon metabolism in cancer | hsa05230 | |||
Cell Process | Aerobic glycolysis | |||
Cell apoptosis | ||||
In-vitro Model | LN-18 | Glioblastoma | Homo sapiens | CVCL_0392 |
LN-229 | Glioblastoma | Homo sapiens | CVCL_0393 | |
SHG-44 | Astrocytoma | Homo sapiens | CVCL_6728 | |
U251 (Fibroblasts or fibroblast like cells) | ||||
U87 (A primary glioblastoma cell line) | ||||
Temozolomide
[Approved]
In total 1 item(s) under this drug | ||||
Experiment 1 Reporting the m6A-centered Drug Response | [1] | |||
Response Summary | Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDH kinase 1 (PDK1) mRNA in an m6A-dependent manner in glioblastoma multiforme cells. JPX interacted with N6-methyladenosine (m6A) demethylase FTO alpha-ketoglutarate dependent dioxygenase (FTO) and enhanced FTO-mediated PDK1 mRNA demethylation. | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Responsed Disease | Glioblastoma | ICD-11: 2A00.00 | ||
Pathway Response | Citrate cycle | hsa00020 | ||
Central carbon metabolism in cancer | hsa05230 | |||
Cell Process | Aerobic glycolysis | |||
Cell apoptosis | ||||
In-vitro Model | LN-18 | Glioblastoma | Homo sapiens | CVCL_0392 |
LN-229 | Glioblastoma | Homo sapiens | CVCL_0393 | |
SHG-44 | Astrocytoma | Homo sapiens | CVCL_6728 | |
U251 (Fibroblasts or fibroblast like cells) | ||||
U87 (A primary glioblastoma cell line) | ||||
References